Crossmark

Racial differences in long-term adjuvant endocrine therapy adherence and mortality among Medicaid-insured breast cancer patients in Texas: Findings from TCR-Medicaid linked data

Crossref DOI link: https://doi.org/10.1186/s12885-018-5121-z

Published Online: 2018-12-04

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Farias, Albert J. http://orcid.org/0000-0002-6463-7831
Wu, Wen-Hsing

Du, Xianglin L.
Funding

Funding for this research was provided by:

National Cancer Institute (R25-CA57712)

Agency for Healthcare Research and Quality (R01-HS018956)

Cancer Prevention and Research Institute of Texas (RP130051)
License Information

Text and Data Mining valid from 2018-12-01

Version of Record valid from 2018-12-04
More Information

Article History

Received: 5 October 2017

Accepted: 21 November 2018

First Online: 4 December 2018

Ethics approval and consent to participate

: The study was reviewed by the Institutional Review Board at the University of Texas Health Science Center at Houston. It was determined to be a retrospective analysis of publicly available, de-identified data and was determined to be exempt from requiring written informed consent.

: Not applicable. No individual person’s data is included.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Document is current

Any future updates will be listed below